RVMD
RVMD
NASDAQ · Biotechnology

Revolution Medicines Inc

Large-Cap Stocks Blue Chip Stocks Biotech Stocks Healthcare Stocks
$169.51
+3.70 (+2.23%)
As of Jun 23, 9:40 PM ET ·
Analyst Consensus
Strong Buy
27
Analysts
High
Coverage
Buy 26 96%
Hold 1 4%
Sell 0 0%
Price Target
Analyst Price Target -32.7% upside
Low Target $80.83
Average Target $114.11
High Target $120.13
Current Price $169.51
Current
$169.51
Target
$114.11
$80.83 $114.11 avg $120.13
Scenario Analysis
Bear Case
$80.83
-52.3%
Low target
Base Case
$114.11
-32.7%
Avg target
Bull Case
$120.13
+-29.1%
High target
Risk/Reward
0.6x
Unfavorable
Price in Context
52-Week High
$166.50
1.8% from high
52-Week Low
$34.00
+398.6% from low
50-Day SMA
$94.85
+78.7% vs SMA
200-Day SMA
$58.23
+191.1% vs SMA
RSI (14)
62.5
Neutral
Target vs 52W High
$114.11
-31.5% vs high
Peer Consensus — Biotechnology
Stock Consensus Analysts Buy % Target Upside
ABBV
Abbvie Inc
 Strong Buy 40 78% $257.58 +9.7%
AMGN
Amgen Inc
 Hold 44 50% $190.87 -45.0%
GILD
Gilead Sciences Inc
 Strong Buy 39 82% $362.68 +190.0%
VRTX
Vertex Pharmaceuticals Inc
 Strong Buy 40 83% $438.34 -6.4%
REGN
Regeneron Pharmaceuticals
 Buy 38 71% $76.80 -87.6%
ALNY
Alnylam Pharmaceuticals Inc
 Strong Buy 37 76% $102.31 -64.5%
RVMD
Revolution Medicines Inc
 Strong Buy 27 96% $114.11 -32.7%
NTRA
Natera Inc
 Strong Buy 27 89% $142.91 -39.1%